Milind Deshpande
CIK: 0001378588
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPRO
Spero Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Deshpande Milind
Deshpande Milind (SEC CIK 0001378588) files insider reports with the SEC as Director of Spero Therapeutics, Inc. (SPRO).
Signal8 holds 2 ownership filings by Deshpande Milind, all Form 4s, filed between Jun 16, 2025 and Jun 25, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Deshpande Milind's filings is in CAMBRIDGE, MA.
Recent filings by Deshpande Milind
Other insiders filing for Spero Therapeutics, Inc. (SPRO)
- Zack Debra, Chief Medical Officer
- Tregoning Kathleen, Director
- Smith Cynthia, Director
- VINK PATRICK V.J.J., Director
- THOMAS FRANK E, Director
- Jackson Scott Thomas, Director